<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03036774</url>
  </required_header>
  <id_info>
    <org_study_id>2014/30</org_study_id>
    <secondary_id>2015-A01997-47</secondary_id>
    <nct_id>NCT03036774</nct_id>
  </id_info>
  <brief_title>Gastric Volume and Diabetes</brief_title>
  <acronym>ECHODIABETE</acronym>
  <official_title>Quantitative Ultrasound Assessment of Gastric Volume in Diabetic and Non Diabetic Patients Scheduled for a General Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hopital Foch</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hopital Foch</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective is to compare the frequency of a &quot; full stomach &quot; in diabetic patients
      compared with a control population, all the patients having followed the instructions of
      preoperative fast.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 14, 2017</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">January 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients with full stomach</measure>
    <time_frame>one day</time_frame>
    <description>The main objective is to compare the frequency of a &quot;full stomach&quot; in the diabetic population compared to a &quot;control&quot; population just before induction of general anesthesia.
A &quot;full stomach&quot; is defined by an antral area &gt; 340 mm2
The main objective is to compare the frequency of a &quot;full stomach&quot; in the diabetic population compared to a &quot;control&quot; population just before induction of general anesthesia.
A &quot;full stomach&quot; is defined by an antral area &gt; 340 mm2</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Glycemia</measure>
    <time_frame>one day</time_frame>
    <description>To assess the relationship between preoperative blood glucose and gastric emptying in the diabetic population</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fast duration</measure>
    <time_frame>one day</time_frame>
    <description>To compare the impact of the duration of fasting on the gastric residue in both populations of patients (diabetic and non-diabetic)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glycated hemoglobin</measure>
    <time_frame>one day</time_frame>
    <description>To assess the relationship between glycated hemoglobin and gastric emptying in the diabetic population</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of anxiety using a numerical scale (from 0 -no anxiety- to 10 -maximal anxiety-)</measure>
    <time_frame>one day</time_frame>
    <description>To compare the impact of anxiety on the gastric residue in both populations of patients (diabetic and non-diabetic) in both populations of patients (diabetic and non-diabetic)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of anxiety using a numerical scale (from 0 -no pain- to 10 -maximal pain-)</measure>
    <time_frame>one day</time_frame>
    <description>To compare the impact of pain on the gastric residue in both populations of patients (diabetic and non-diabetic) in both populations of patients (diabetic and non-diabetic)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraoperative hypoxemia</measure>
    <time_frame>one day</time_frame>
    <description>Evaluation of the risk of intraoperative pulmonary inhalation in both populations of patients (diabetic and non-diabetic)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">245</enrollment>
  <condition>Diabetes</condition>
  <arm_group>
    <arm_group_label>Diabetic patient</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Non diabetic patient</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ultrasonic measurement of antral area</intervention_name>
    <description>Ultrasonic measurement of antral area</description>
    <arm_group_label>Diabetic patient</arm_group_label>
    <arm_group_label>Non diabetic patient</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients aged over 18

          -  American Society of Anesthesiologists (ASA) classification 1 to 3

          -  needed a general anesthesia for a programmed surgical intervention

        Non inclusion Criteria:

          -  Pregnant or breastfeeding women

          -  patients already operated or to be operated from the upper digestive tract (esophagus,
             stomach, duodenum)

          -  patients treated with a prokinetic treatment and / or a level 3 analgesic

        Exclusion criteria

          -  unfeasibility to ultrasound measurement of antral area

          -  failure to observe fasting instructions
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Julien Rousset, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital Tenon</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marc Fischler</last_name>
    <role>Study Chair</role>
    <affiliation>Hôpital Foch</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Francis Bonnet, MD-PhD</last_name>
    <role>Study Chair</role>
    <affiliation>HopitalTenon</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marc Fischler, MD-PhD</last_name>
    <phone>+33(0)146252442</phone>
    <email>m.fischler@hopital-foch.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>AP-HP Hopital Tenon</name>
      <address>
        <city>Paris</city>
        <zip>75020</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julien Rousset, MD</last_name>
      <phone>+33(0)56017000</phone>
      <email>francis.bonnet@aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Julien Rousset, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital Foch</name>
      <address>
        <city>Suresnes</city>
        <zip>92150</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc Fischler, MD-PhD</last_name>
      <phone>+33(0)146252442</phone>
      <email>m.fischler@hopital-foch.org</email>
    </contact>
    <investigator>
      <last_name>Marc Fischler, MD-PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 27, 2017</study_first_submitted>
  <study_first_submitted_qc>January 27, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 30, 2017</study_first_posted>
  <last_update_submitted>April 19, 2017</last_update_submitted>
  <last_update_submitted_qc>April 19, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Gastric contents</keyword>
  <keyword>Ultrasound</keyword>
  <keyword>Diabetes</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

